This is a preview of subscription content, log in via an institution to check access.
Notes
single technology appraisal
Reference
Evitt L, et al. Cost-Effectiveness Evaluation of Vortioxetine in Major Depressive Episode in the UK Setting. 19th Annual European Congress of the International Society for Pharmacoeconomics and Outcomes Research : (plus poster) abstr. PMH26, 29 Oct 2016. Available from: URL: http://www.ispor.org/RESEARCH_STUDY_DIGEST/list.asp?qs=46703.
Rights and permissions
About this article
Cite this article
Vortioxetine "relevant" option for treating MDEs. PharmacoEcon Outcomes News 767, 1 (2016). https://doi.org/10.1007/s40274-016-3561-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-016-3561-8